<code id='BF464E8E27'></code><style id='BF464E8E27'></style>
    • <acronym id='BF464E8E27'></acronym>
      <center id='BF464E8E27'><center id='BF464E8E27'><tfoot id='BF464E8E27'></tfoot></center><abbr id='BF464E8E27'><dir id='BF464E8E27'><tfoot id='BF464E8E27'></tfoot><noframes id='BF464E8E27'>

    • <optgroup id='BF464E8E27'><strike id='BF464E8E27'><sup id='BF464E8E27'></sup></strike><code id='BF464E8E27'></code></optgroup>
        1. <b id='BF464E8E27'><label id='BF464E8E27'><select id='BF464E8E27'><dt id='BF464E8E27'><span id='BF464E8E27'></span></dt></select></label></b><u id='BF464E8E27'></u>
          <i id='BF464E8E27'><strike id='BF464E8E27'><tt id='BF464E8E27'><pre id='BF464E8E27'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:5
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Medicare inequities exacerbate Puerto Rico’s health disparities
          Medicare inequities exacerbate Puerto Rico’s health disparities

          RamonEspinosa/APWhenIaccompanymyfathertohisregularcardiologistappointmentinPuertoRico,worryandsadnes

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          NIH study of ME/CFS points to clear biological hallmarks

          AlisonSbranaattheNIHClinicalCenterinBethesda,Md.,participatesinastudyonmyalgicencephalomyelitis/chro